PTGDS and neoplasm: Another study also showed that MSC-derived EV, prostaglandin D2 synthase (L-PGDS) reduced the levels of stem cell markers (such as Oct4, Nanog, and Sox2) and suppressed the phosphorylation of STAT3, thereby affecting CSC properties and tumor progression [94].